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Hollow organs and tissue systems drive various functions in the body. Many of these
hollow or tubular systems, such as vasculature, the intestines, and the trachea, are
common targets for tissue engineering, given their relevance to numerous diseases
and body functions. As the field of tissue engineering has developed, numerous
benchtop models have been produced as platforms for basic science and drug testing.
Production of tubular scaffolds for different tissue engineering applications possesses
many commonalities, such as the necessity for producing an intact tubular opening and
for formation of semi-permeable epithelia or endothelia. As such, the field has converged
on a series of manufacturing techniques for producing these structures. In this review,
we discuss some of the most common tissue engineered applications within the context
of tubular tissues and the methods by which these structures can be produced. We
provide an overview of the general structure and anatomy for these tissue systems
along with a series of general design criteria for tubular tissue engineering. We categorize
methods for manufacturing tubular scaffolds as follows: casting, electrospinning, rolling,
3D printing, and decellularization. We discuss state-of-the-art models within the context
of vascular, intestinal, and tracheal tissue engineering. Finally, we conclude with a
discussion of the future for these fields.
Keywords: biomaterials, 3D printing, electrospinning, decellularization, lumen, vascular, intestine, trachea
INTRODUCTION
Function of the human body is dependent on tubular tissues and tissue structures. These tissues,
including vasculature, the intestines, the trachea, and many others, serve various roles in the
body, ranging from absorption of nutrients to transport of oxygen. As may be expected given the
broad assortment of functions associated with tubular tissues, these structures are susceptible to
a variety of diseases and traumas. As such, significant focus has been placed on the generation of
models of tubular systems for studies in disease, basic science, and drug discovery/efficacy. Many
of these models utilize tissue engineering principles to recreate the function of these systems on
the benchtop without requiring use of animal models (Bitar and Raghavan, 2012; Seifu et al., 2013;
Law et al., 2016). The methods used to manufacture these tissue engineered systems play a major
role in their resultant function. Here, we review the construction of tissue engineered systems for
generating tubular models.
Tubular tissues have many unifying structural characteristics despite their various functions.
Generally, these tissues are constructed in a lamellar manner, with sequential layers of tissue
surrounding an internal opening. This opening, called the lumen, is where transport and
containment of the specific medium for a particular tubular tissue occurs. This lumen is lined with
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a set of barrier-forming cells, called an epithelium (or
endothelium in the case of vasculature). This structure
functions to separate the internal contents of the lumen
from the surrounding tissues and organs, while allowing selective
permeation and transport across the epithelium. The epithelium
is situated on a bed of extracellular matrix (ECM), which provides
structural support for the lumen and the epithelium (Hendow
et al., 2016). This ECM layer can be present in various forms,
but it generally consists of cells embedded in connective tissue,
including various proteins like collagen, elastin, etc. Depending
on the function of the particular tissue, other tissue layers may
also be present. For example, given the role of vasculature in
moving blood throughout the body, blood vessels often contain
a layer of smooth muscle, which assists in the vasodilation and
constriction in the vascular system. Regardless of the particular
function for a tubular tissue, the main purpose of these structures
involves the separation of one media from another, guiding and
transporting various fluids, gases, and solids.
Tissue engineering is the combination of cells and a template
to generate a structure that recapitulates the native function of a
specific tissue or tissue system. Often the template is a scaffold
or hydrogel on which the cells can proliferate and produce ECM.
Here, we discuss scaffolds and hydrogels nearly synonymously,
as the manufacturing methods for producing a tubular scaffold
versus a tubular hydrogel do not necessarily differ. However,
these structures possess different fundamental properties, and
each should be considered independently for a given application.
An understanding of the native function and physiology of a
tissue is often sufficient to inform the choice of cells and scaffold
materials for a tissue engineered application. However, scaffold
design is challenging, given the need to create a supportive
structure for cells to grow and create the desired tissue, without
impinging on the overall function of the resultant structure.
These challenges are especially prominent in the design of tubular
systems, given the need to create an intact lumen that can support
the formation of an epithelium and other components. Various
manufacturing approaches have been utilized for production
of scaffolds, including casting, electrospinning, rolling, three-
dimensional (3D) printing, and decellularization.
Determination of the resultant properties in tubular systems
can be difficult, particularly due to geometry. Besides the
manufacture of a tubular scaffold, characterization of the
interaction between cellular and scaffold components, as well
as their combined structural integrity, is fundamental. For
example, the formation and continued integrity of the epithelial
or endothelial barrier ensures the selective permeability of
essential nutrients and metabolic by-products, while preventing
the entrance of noxious or pathogenic compounds. Thus, without
successful barrier formation, and characterization of such, the
functionality and even survival of these models would be limited.
Equally, any drug transport studies would be rendered invalid
if barrier formation was insufficient. Intercellular junctions,
provide this barrier function and consist of various proteins, such
as cadherins, zonulin-1 (ZO-1), etc. Generally, membranes like
the intestinal epithelium possess tight junctions, which highly
regulate ionic/molecular passage across the epithelium, whereas
the vascular endothelium, for example, is more permeable.
In this review, we discuss techniques commonly used to
generate tissue engineered scaffolds for tubular systems. Our aim
is to provide a categorization of the available methodologies for
scaffold production to assist tissue engineers in navigating this
extensive field. As such, we have chosen to focus on three specific
tissue systems that represent various design challenges in the
field: vasculature, the intestine, and the trachea for recapitulating
the functions of many tubular tissue systems present in the
body. Initially, we discuss the anatomy of these systems and
some of the general criteria for tubular scaffold design. Then, we
categorize the available scaffold manufacturing techniques. We
proceed to examine some the applications of these techniques
for our chosen tissue systems. Finally, we conclude with a
discussion of the future for tissue engineered scaffold design for
tubular tissue systems.
Structure of Native Tubular Tissues
Various tubular tissues are present in the body, including the
vascular system, digestive system, respiratory system, lymphatic
system, reproductive system, and many others. As discussed
above, we have chosen to highlight vasculature, intestines, and
the trachea, as these applications are some of the most widely
researched in terms of generation of tubular tissue engineered
models (Bitar and Raghavan, 2012; Seifu et al., 2013; Hendow
et al., 2016; Law et al., 2016). Additionally, these systems possess
various functions that differentiate them from one another with
respect to design. Below, we discuss the specifics of the structure
and physiology for each of these systems.
Vascular Structure
The primary role of the vascular system is the transport of blood
throughout the body at relatively high velocities (Riva et al.,
1985; Klarhöfer et al., 2001), generating significant fluid shear
stress on the walls of a blood vessel (Akintewe et al., 2017).
Additionally, the vascular endothelium is relatively permeable,
allowing transport of biochemical factors through the vascular
wall and even cells during some disease states (Park-Windhol and
D’Amore, 2016). Blood vessels range in size from capillaries and
microvasculature, which are only microns in diameter (Sieminski
and Gooch, 2000), to larger veins and arteries, which can
be ∼30mm in diameter in the case of the pulmonary artery
(Kuriyama et al., 1984). Small capillaries, such as those that
make up the blood brain barrier, can consist of only one cell,
wrapped onto itself to create the interior lumen (Abbott et al.,
2006). However, we will focus on larger blood vessels that have
a lamellar structure divided into three layers (Figure 1A): the
tunica intima, tunica media, and tunica adventitia. Generally, the
intima contains the endothelium, the media is composed of a
layer of smooth muscle, and the adventitia consists of a layer
of connective tissue (James and Allen, 2018). The endothelial
layer of cells makes up the vascular wall. These cells form a
semi-permeable membrane that allows transport of nutrients,
oxygenation, and waste removal from surrounding tissues (Park-
Windhol and D’Amore, 2016). The layer of smooth muscle in
the tunica media aids in control of vasodilation, which can
regulate local blood flow. Lastly, the tunica adventitia provides
support for the internal layers in addition to housing a variety of
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FIGURE 1 | (A) Structure of native tubular tissue systems. Specifically, this schematic highlights the structure of vasculature, the intestines, and the trachea.
(B) Typical structure for tissue engineered tubular systems corresponding the native systems in (A).
nerves, immune cells, and other support systems for vasculature
(James and Allen, 2018). The heart pumps blood through the
luminal compartment of these vessels. This pumping creates
relatively high rates of fluid flow, ∼30 mL/min (Klarhöfer et al.,
2001), thereby generating significant fluid shear on the walls of
vasculature, which is an additional necessary consideration in any
tissue engineered model.
Intestinal Structure
The intestines are a portion of the gastrointestinal tract, which
extends from the mouth, through the esophagus, the stomach, the
small intestines, the large intestines, and finally to the rectum and
anus. The main function of the intestine is to absorb nutrients
from food and liquids we ingest and expel the remaining waste
out of the body, with each portion of the gastrointestinal tract
consisting of four layers. Starting from the interior lining of
the lumen, these layers are the mucosa, submucosa, muscularis
propria, and serosa (Figure 1A). In this review, we focus on
the intestines and describe the layers in the context of these
organs, versus other portions of the gastrointestinal tract. The
mucosa contains the intestinal epithelium and has absorptive,
secretory, and protective functions. The intestinal epithelium is
a tight barrier system, robustly separating the interior contents of
the lumen from the surrounding tissue (Suzuki, 2013). Intestinal
epithelial tissue has a complex 3D structure, consistent of luminal
projections, called villi, with intermediate invaginations, called
crypts (Santos et al., 2018). This 3D architecture maximizes
interior surface area, aiding in nutrient adsorption (Rao and
Wang, 2010). The intestinal epithelium consists of numerous
cell types with various functions, which have a semi-regimented
distribution along this 3D structure. Generally, these cells and
their respective functions are as follows: enterocytes – absorption
of nutrients and formation of intestinal barrier; goblet cells –
secretion of mucin; enteroendocrine cells – sensing of nutrients
and microbes and communication with the enteric nervous
system; transit amplifying cells – differentiation toward secretory
or absorptive lineages; as well as tuft cells, Paneth cells, intestinal
stem cells, and others (Santos et al., 2018). These epithelial cells
are adhered to the lamina propria, a layer of connective tissue,
which is surrounded by a sheet of smooth muscle cells. The
next layer is the submucosa, which contains a series of immune
cells, nerves, and lymphatic cells. This layer is surrounded by the
muscularis propria, which provides peristaltic pumping through
muscle cells, performing the critical function of gut motility.
Finally, the outermost layer is the serosa, or in some cases the
adventitia depending on the present populations of cells, which
forms a barrier around the gastrointestinal tract (Rao and Wang,
2010). The gut also possesses a complex series of nerves called the
enteric nervous system, which consist of two parallel nerve plexi,
the submucosal plexus and myenteric plexus, which run along
the length of the gastrointestinal tract (Furness, 2012). Lastly,
the interior of the gut contains a large cohort of bacteria, called
the gut microbiome, which can influence various other organs
throughout the body (Cryan et al., 2019), in addition to further
complicating tissue engineered design.
Tracheal Structure
The trachea is fundamental in swallowing, speech and respiratory
processes. It resides below the upper airways (nasal cavity, larynx,
pharynx) and forms part of the lower airways (trachea, bronchi,
bronchioles, alveoli), with its main function to conduct and warm
air (Brand-Saberi and Schäfer, 2014). The trachea is comprised
of four main layers (Figure 1A): mucosa, submucosa, hyaline
cartilage, and adventitia. The mucosa contains a pseudostratified
epithelium, which lines the lumen and contains many cell types
including secretory club cells, ciliated cells, mucus producing
goblet cells, basal stem cells, and pulmonary neuroendocrine
cells. Ciliated, mucus-producing, and secretory cells act in
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coordination to aid mucociliary clearance and protection against
infection, while basal cells aid in regenerative processes (Brand-
Saberi and Schäfer, 2014). The submucosa is a connective
tissue layer containing submucosal glands, which contribute to
mucus secretion. The cartilage layer consists of horseshoe-like
rings of hyaline cartilage joined by fibroelastic tissue, which,
is closed posteriorly by a membranous structure consisting of
longitudinally oriented smooth muscle. Lastly, the adventitia
consists of connective tissue. Both the cartilage and adventitial
layers are fundamental in producing the unique structural
and mechanical properties of the trachea. For example, the
specific flexibility which permits the rotation and flexion of
the neck while also maintaining sufficient structural strength
to withstand compression and pressure alterations during
respiratory processes. In order to reflect and integrate with
the in vivo environment, tracheal tissue engineered models
must adhere to these mechanical requirements (Boazak and
Auguste, 2018).The adventitia also houses numerous other cell
types, such as fibroblasts, adipocytes, nerves, and connections
to vasculature, which is essential in meeting blood, nutrient,
and metabolic demands. The respiratory system requires an
air-liquid interface between the interior of the lumen and the
surrounding epithelium (Pezzulo et al., 2011; de Souza Carvalho
et al., 2014), creating a different environment from the fluidic
environments of the vascular and intestinal systems, which can
be difficult to produce in tissue engineered models. Unlike the
in vitro models discussed for vasculature and the intestine, the
outlook for tracheal tissue engineering so far largely concerns
implantable scaffolds for tracheal replacement (Bogan et al., 2016;
Law et al., 2016; Etienne et al., 2018). Indeed, the trachea is subject
to a range of airway disorders which may result from infection,
stenosis, collapse, or cancer (Etienne et al., 2018). The rise of
biomedical engineering approaches, which recapitulate tracheal
tissue, have been largely motivated by these applications. Here,
we will discuss some of these studies, which focus on implant
generation, and how they can be further developed for use as
benchtop disease models.
Design Criteria for Tissue Engineering
Tubular Systems
The physiology of tubular tissues is often complex, requiring
various factors to produce an approximate model of the desired
tissue. Generally, tissue engineered systems utilize a cell type
(or types) in combination with a scaffold to recreate the
primary function (or functions) of the tissue. However, choosing
appropriate cell types and scaffold architectures can be difficult.
Here, we have highlighted some of the necessary design criteria
to consider for manufacturing a scaffold for tubular tissue
engineering (Table 1).
Scaffold design for tubular systems presents a variety of
challenges. First, one must consider the source and types of cells,
with any tubular system requiring a source of epithelial cells.
However, the exact behavior of these cells will vary depending
on the tissue in question. Epithelial cells are often co-cultured
with ECM-producing cells like fibroblasts or smooth muscle cells
(Boland et al., 2004; Yoshikawa et al., 2011; Chen et al., 2015),
but even the type of matrix-producing cell can vary depending
on application. For example, the trachea requires production
of cartilaginous ECM using chondrocytes (Lin et al., 2009)
or mesenchymal stem cells differentiated along chondrogenic
pathways (Asnaghi et al., 2009; Haykal et al., 2014). Different
tissues will also require different supporting cells. For example,
native intestinal epithelium contains goblet cells for producing
mucus (Dosh et al., 2019). Both native vasculature and intestine
possess a layer of musculature (Boland et al., 2004), necessitating
sourcing of appropriate muscle cells. We have summarized some
common cell lines or primary cells used to reconstitute native
function in tissue engineered models (Table 2).
A major requirement for every tubular scaffold is the
formation of a contiguous epithelial or endothelial lining
(Figure 1B). Cells are most effectively seeded homogenously on
two-dimensional (2D), non-porous surfaces, such as cell culture
flasks, or in injectable media, such as hydrogels. However, tubular
scaffolds are not flat and, generally, are porous. Therefore, the
necessity for homogenous seeding on a 3D surface, requires
alternative methodologies. For example, researchers have seeded
cells onto flat membranes and then rolled these membranes
into tubes (Yuan et al., 2012; Cheng et al., 2017; Zhao et al.,
2018). Other studies have used dynamic methods, relying on the
cells to adhere homogenously to the surrounding walls through
rotational or pressurized actuation (Niklason and Langer, 1997;
Godbey et al., 2004; Nieponice et al., 2008). Porous scaffolds are
beneficial in that they provide greater access to media by cells, but
these pores also make the formation of a contiguous epithelium
difficult. Some studies have back-filled pores with ECM-
producing cells or depositing cells in a layered approach to assist
in the formation of an epithelium (Liu et al., 2015; Chen et al.,
2015). Many implant-driven studies also rely on cell infiltration
in vivo. All of these methods have limitations, but continuous
iteration has improved the feasibility of accomplishing this
particular task for tubular tissue engineering.
TABLE 1 | Design criteria for tubular tissue engineered scaffold development as a function of tissue type.
Tissue System Cellular Mechanical Other
Contiguous Smooth Supporting Mucous Fluid Pressuri Mechanical Separation Air-liquid
Epithelium/ Muscle Connective Layer Shear zation Stimulation of Luminal Interface
Endothelium Layer Tissue Layer (Peristalsis) Chamber
Vasculature X X X X X
Intestine X X X X X X X X
Trachea X X X X X X
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TABLE 2 | Commonly used cells for tissue engineered models of vasculature, the intestine, and the trachea.
Tissue System Native Tissue Layer Cell Model Cell Function References
Blood Vessel Tunica Intima Human Umbilical Vein Endothelial Cell (HUVEC) Endothelial Cell Boland et al., 2004; Lovett et al.,
2007; Du et al., 2012; Wang et al.,
2014; Cui et al., 2019
Endothelial Progenitor Cell (EPC) Endothelial Cell Neff et al., 2011; Ju et al., 2017;
Atchison et al., 2017
Primary Endothelial Cell Endothelial Cell Matsuda, 2004, 200; Opitz et al.,
2004; Zang et al., 2013
Tunica Media Primary Smooth Muscle Cells Smooth Muscle Cell Seliktar et al., 2003; Opitz et al.,
2004; Swartz et al., 2005; Lee et al.,
2007; Zhang et al., 2013; Fu et al.,
2014; Cui et al., 2019
Tunica Adventitia Dermal Fibroblasts Fibroblast Seliktar et al., 2003; Boland et al.,
2004
Intestine Mucosa Caco-2 Cells Enterocyte Costello et al., 2014; Chen et al.,
2015; Ladd et al., 2018
HT-29-MTX Cells Goblet Cell Chen et al., 2015
Submucosa Primary Intestinal Myofibroblast Myofibroblast Chen et al., 2015
Muscularis Propria Smooth Muscle Cell Smooth Muscle Cell Zakhem et al., 2012; Knight et al.,
2013Serosa
Trachea Mucosa Primary Respiratory Epithelial Cell Epithelial Cell Butler et al., 2017; Kreimendahl et al.,
2019; Park et al., 2019
Turbinate Mesenchymal Stromal Cell Epithelial Cell Park et al., 2018; Ahn et al., 2019
Submucosa
Hyaline Cartilage Mesenchymal Stem Cell Chondrocyte Wang et al., 2020
Adipose-derived Stem Cell Chondrocyte Giraldo-Gomez et al., 2019
Auricular Chondrocyte Chondrocyte Park et al., 2019
Adventitia Nasal Fibroblast Fibroblast Kreimendahl et al., 2019
Another necessary design consideration is provision of
nutrients to all cells in the system. Tubular systems will
inherently contain epithelial cells, but they may also contain
supporting cells, present underneath the epithelium (Figure 1B).
In the case of vascular systems, these underlying cells can
theoretically receive nutrients through the endothelial wall, as the
vascular endothelium is inherently permeable for this purpose.
However, intestinal and respiratory tissue engineering presents
a particular challenge, as the lumen should not be used to
provide nutrients to any of the cells in the system, given the
function of these tissues (Bitar and Raghavan, 2012). In the body,
nutrients are provided to the tissues underlying the epithelium
by surrounding vasculature. To mimic native tissues, tissue
engineered models rely on perfusion of the scaffold with media to
simulate nutrient transport. However, separation of the luminal
compartment from the surrounding scaffold is difficult. Custom
bioreactors can accomplish this task (Haykal et al., 2014; Zhou
et al., 2018), but bioreactor design and setup also complicate
culture for the system.
Secondary design criteria relate to the specific function of
the tubular system. For example, vascular systems often induce
fluid movement to mimic blood flow. As such, vascular systems
utilize external pumps, typically with pulsatile pumping patterns
(Niklason and Langer, 1997; Niklason et al., 1999; Opitz et al.,
2004), which also necessitates the ability of the scaffold to
withstand mechanical forces that result from pumping, i.e.
pressurization and fluid shear (Figure 2). Fluid shear is also
known to drive vascular endothelial phenotype and morphology
(Wang et al., 2013; Wang et al., 2016a; Polacheck et al.,
2017) and regulates angiogenesis in vitro (Song and Munn,
2011; Galie et al., 2014), which can be beneficial in different
tissue engineering models. An accurate intestinal model requires
peristaltic pumping to mimic gut motility. Peristalsis has been
achieved using external bioreactors (Zhou et al., 2018), but
FIGURE 2 | Stresses present for dynamic flow of a fluid through a tube.
(A) Pumping a liquid or gaseous medium through a tube will generate a
pressure on the tube walls. The highest stress resultant from this
pressurization is the hoop stress (σh). Any scaffold must possess sufficient
strength to compensate for this hoop stress. (B) Fluid movement will also
result in a shear stress (τs) on the walls of the tube. Generally, these factors
(σh and τs) can be calculated based on the geometry of the tube, i.e., wall
thickness (t) and inner radius (r), the pressure (p) on the tube walls, the flow
rate of the fluid (v), and the viscosity of the fluid. However, these calculations
are complicated by scaffold porosity and the potential for effects of cell growth
on the scaffold over the course of an experiment.
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bioreactors are often custom-made, requiring further design
and optimization. Secondarily, native intestinal environments
contain a bacterial cohort. Inputting of bacteria into a tissue
engineered lumen is feasible (Costello et al., 2014) but also further
complicates culture conditions. Other systems, like the trachea,
require the presence of air in the lumen, which can make culture
condition more complex. Many studies have utilized bioreactors
that rotate the tubular tracheal scaffold along its axis with half of
the scaffold submerged in media and the other half in air to create
an air-liquid interface (Lin et al., 2009). However, this approach
is not ideal for biomimetic studies assessing drug delivery, given
its dissimilarities to the native tracheal environment.
METHODS FOR FABRICATING TUBULAR
SCAFFOLDS
Various methodologies can be used to produce tubular scaffolds
for tissue engineering. We have divided these techniques into
five categories (Table 3) to assist in experimental design and
planning. Below, we have discussed the general methodologies
for each technique, while also addressing their benefits and
limitations. Other reviews have also examined general strategies
for tissue engineering tubular systems (Bitar and Raghavan,
2012; Seifu et al., 2013; Hendow et al., 2016; Law et al., 2016;
Song et al., 2018).
Casting
Casting is one of the most commonly used manufacturing
techniques across the entirety of the tissue engineering field.
The basis for this methodology is the pouring or injection of
a liquid into a mold, at which point the liquid is induced
to form a solid structure. The liquid can be derived from a
variety of means, including the melting and solidification of a
material (Im et al., 2019), the solubilization of a material in
a solvent and subsequent evaporation of the solvent (Mooney
et al., 1995; Opitz et al., 2004; Nieponice et al., 2008; Ma et al.,
2010; Zakhem et al., 2012), or the cross-linking (Matsuda, 2004;
Guo et al., 2017) or gelation of a material into a solid or semi-
solid structure, such as a hydrogel (Wang et al., 2014; Strobel
et al., 2018b). Casting is also applicable within the context of
more complex molding techniques, such as vacuum-assisted tube
formation (Singh et al., 2017), and for the formation of more
complex structures (Ladd et al., 2018). As may be expected, the
chosen material will dictate the mechanism. In the case of some
hydrogels, particularly biomolecular gels, e.g., collagen, fibrin,
etc., cells can be cast with the gel (Seliktar et al., 2003; Swartz
et al., 2005; Liu et al., 2007; Naito et al., 2011; Atchison et al.,
2017, 2020). This method is convenient and widely applicable,
as it can be used to produce a variety of geometries and shapes
with homogenous cell populations and is compatible with other
manufacturing methods (Atchison et al., 2017; Iannucci et al.,
2019). However, a secondary seeding step is often still necessary
to create the stratified cellular structure of native tubular tissues,
even when using homogeneously seeded hydrogels.
In tissue engineering cases, the inclusion of pores in the final
structure is often necessary to provide nutrient access for seeded
cells. Pores can be created in variety of manners but are often
produced using a secondary material or porogen that can be
removed through post-processing, leaving a pore in its place.
Various porous scaffolds have been produced using ice templating
(Boccaccini et al., 2005; Shin’oka et al., 2005; Nieponice et al.,
2008; Ma et al., 2010; Zakhem et al., 2012; Chen et al., 2015; Roh
et al., 2019). This process involves freezing a solution or mixture
of water and the scaffold material, followed by sublimation of
the ice, also called lyophilization, leaving pores in the resultant
solid structure. Alternatively, pores can be produced by including
orthogonally soluble solids in the casting solution. For example,
salt can be included in solvent-cast polymeric solutions and then
washed out with water after solvent evaporation (Mooney et al.,
1995; Sin et al., 2010; Costello et al., 2014). This technique is only
feasible for highly porous materials, because lower porosities will
prevent access for porogen removal.
Casting is simple, convenient, and compatible with a wide
range of materials, with examples showing the application of
casting techniques for the production of complex models with
stratified layers of cells (Figure 3). However, various factors can
complicate the casting process, including the construction of
larger objects, objects with inconsistent cross-sections, or objects
with internal cavities. In these cases, mold design is particularly
important. Inclusion of vents can ensure filling of the entire mold.
However, releasing the resultant material from a mold can also be
difficult, depending on the material. Regardless, complex shapes
can be cast to generate useful, tissue-like structures (Wang et al.,
2014). Another negative factor affecting casts, particularly solvent
cast polymers and some porogen forming techniques, is the
presence of remnant solvent or toxic porogens that can negatively
affect cell growth. These issues can be avoided with proper
handling and preparation of the cast. Seeding cells into cast tubes
can also be difficult, as discussed above. Many studies seed cells
into the lumen through pipetting. However, the scaffolds often
need to be rotated (Opitz et al., 2004; Atchison et al., 2017,
2020) or subjected to another form of dynamic seeding (Godbey
et al., 2004; Nieponice et al., 2008) to reach homogeneous
seeding on the interior lining of the scaffold. Nevertheless,
casting remains a commonly used mechanism for tubular scaffold
production given its customizability and wide range of accessible
materials. Further, the resultant tubular scaffolds are repeatably
manufacturable, requiring no further steps for assembly after the
initial cast. These factors make this technique widely applicable
in the field of tubular tissue engineering and beyond.
Electrospinning
Electrospinning techniques involve the solubilization of a
polymeric or biomolecular material, which is ejected from a
syringe. During the electrospinning processes, the fluid is charged
through an applied voltage and directed toward a neutral or
oppositely charged mandrel. The solvent evaporates as the
material travels toward the mandrel, creating nanofibers. For the
formation of tubular scaffolds, the mandrel is typically rotated
during the extrusion process. The resultant mesh of nanofibers
can be removed from the mandrel, producing a mesh-tube
(Rocco et al., 2014), with examples producing contiguous tubular
structures that are compatible with cell-seeding (Figure 4).
In many cases these meshes are combined with secondary
electrospinning, deposition, or casting techniques to change
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TABLE 3 | Categorization of techniques for manufacturing tubular scaffolds for tissue engineering.
Fabrication method Advantages Disadvantages References
• Compatible with most material types
• Simple and easy to implement
• Applicable with cell-seeded materials
• Difficult to produce complex shapes
• Processing can result in toxic
byproducts
• Secondary cell seeding method
required
Vasculature
Seliktar et al., 2003; Matsuda, 2004; Opitz et al.,
2004; Swartz et al., 2005; Liu et al., 2007;
Nieponice et al., 2008; Ma et al., 2010; Wang et al.,
2014; Guo et al., 2017; Atchison et al., 2017;
Strobel et al., 2018b; Im et al., 2019
Intestine
Yu et al., 2012; Zakhem et al., 2012; Chen et al.,
2015; Zhou et al., 2018; Ladd et al., 2018, 2019;
Roh et al., 2019
Trachea
Naito et al., 2011
• High degree of control over scaffold
properties (porosity, mechanics, etc.)
• Easily applied for tube formation
• Directly compatible with proteins
• Processing can result in toxic
byproducts
• Secondary cell seeding method
required
• Optimization necessary for
experimental setup
Vascular
Boland et al., 2004; Lee et al., 2007; Smith et al.,
2008; Wang et al., 2009; Han et al., 2011; Du et al.,
2012; Zhang et al., 2013; Fu et al., 2014; Zhou
et al., 2016; Ju et al., 2017; Strobel et al., 2018a;
Rodriguez et al., 2019
Intestine
Yoon and Kim, 2010; Knight et al., 2013
Trachea
Hinderer et al., 2012; Mahoney et al., 2016; Wu
et al., 2017; Best et al., 2018; Kang et al., 2019;
O’Leary et al., 2020
• Cells can be seeded in 2D and rolled
into 3D tube
• Simple and easy to implement
• Production may require handling of
cell-seeded scaffold
• Sealing of tube can be difficult
Vascular
Niklason et al., 2001; Shen et al., 2003; L’Heureux
et al., 2006; Pricci et al., 2009; Konig et al., 2009;
Gauvin et al., 2010; Rayatpisheh et al., 2014; Jung
et al., 2015; Gui et al., 2016; Zhao et al., 2018;
Wang et al., 2018
Intestine
Grikscheit et al., 2002, 2004
• High degree of customization and
control over scaffold production
• Compatible with most material types
• Applicable with cell-seeded materials
• Expensive equipment requires for
production of scaffolds
• Optimization necessary for
experimental setup
• Some printing techniques do not
currently possess high resolution
Vascular
Melchiorri et al., 2016; Rabionet et al., 2018; Cui
et al., 2019
Trachea
Johnson et al., 2016; Gao et al., 2017; Taniguchi
et al., 2018; Hsieh et al., 2018; Park et al., 2018;
Park et al., 2019; Machino et al., 2019; Xia et al.,
2019; Kang et al., 2019; Ahn et al., 2019; Gao
et al., 2019
• Scaffold material is highly
biocompatible
• Intrinsic biochemical factors can benefit
production of tissue engineered model
• Secondary cell seeding method
required
• Decellularized scaffold can contain
biochemical factors that negatively
affect production of tissue engineered
model
• Extensive characterization and quality
control are necessary
Vascular
McFetridge et al., 2007; Xi-Xun et al., 2008; Yang
et al., 2009; Neff et al., 2011; Lee et al., 2012
Intestine
Totonelli et al., 2012
Trachea
Johnson et al., 2016; Butler et al., 2017; Ghorbani
et al., 2017; Zhong et al., 2019; Batioglu-Karaaltin
et al., 2019; Giraldo-Gomez et al., 2019; Wang
et al., 2020
the properties and/or structure of the scaffold. The process of
electrospinning, particularly for scaffold production, has been
covered extensively in previous reviews (Pham et al., 2006;
Rocco et al., 2014).
Electrospinning provides a high degree of control over the
resultant “pore” size of the mesh and the mechanical properties
of the fibers. This process is also compatible with numerous
materials that are suitable for scaffold production (Figure 4).
Most electrospun scaffolds have been produced using polymers,
or polymers mixed with ECM proteins (Vaz et al., 2005; Buttafoco
et al., 2006; Lee et al., 2007; Smith et al., 2008; Wang et al.,
2009; Yoon and Kim, 2010, 201; Han et al., 2011; Du et al.,
2012; Hinderer et al., 2012; Zhang et al., 2013; Knight et al.,
2013; Fu et al., 2014; Ott et al., 2016; Mahoney et al., 2016;
Zhou et al., 2016; Wu et al., 2017; Ju et al., 2017; Best et al.,
2018; Strobel et al., 2018a; O’Leary et al., 2020). However, some
scaffolds have purely utilized proteins (Boland et al., 2004).
Electrospun scaffolds suffer from the same disadvantages as
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FIGURE 3 | Example of tubular scaffold for intestinal tissue engineering constructed through the casting process (Chen et al., 2015). (A) Schematic showing scaffold
production. Silk is lyophilized in a mold to create a porous scaffold with a central lumen. Cells are seeded into the scaffold and into the interior of the lumen.
(B) Image showing scaffold lumen. Scale bar is 4 mm. (C) Immunostain for ZO-1 and cell nuclei (DAPI). Scale bar is 100 µm. (D) Scanning electron microscopic
(SEM) image of epithelial lining. Scale bar is 1 µm. (E) Alkaline phosphatase (ALP) staining for ALP enzymatic activity on interior lining of lumen. Scale bar is 200 µm.
(F) Confocal z-stack of cells in scaffold immunostained for SM22a, a marker for myofibroblasts. Scale bar is 50 µm. Images were reordered from multiple panels,
and lettering has been relabeled for consistency as part of this review article (Chen et al., 2015). These images are reprinted under Creative Commons Attribution 4.0
International License, available at http://creativecommons.org/licenses/by/4.0/.
FIGURE 4 | Example of electrospinning process for manufacturing a tubular scaffold for vascular tissue engineering (Lee et al., 2007). (A) Schematic of
electrospinning process. (B) Schematic of spinning mandrel for tubular scaffold production. (C) SEM image of bulk scaffold, produced from collagen, elastin, and
polymeric mixture, at 18x magnification. (D) SEM image of scaffold from inset in (C) at 500x magnification. (E) Hematoxylin and eosin histological stain of scaffold
seeded with smooth muscle cells. Images were reordered from multiple panels, and lettering has been relabeled for consistency as part of this review article (Lee
et al., 2007).
the cast scaffolds above, namely toxicity from remnant solvent
and potential difficulties in homogeneous cell seeding. However,
both of these criteria have been examined extensively. A similar
technique to electrospinning, called gel spinning, has also been
used for tubular scaffold production, where high viscosity gels
are extruded onto a spinning mandrel (Lovett et al., 2008;
Rodriguez et al., 2019). Generally, electrospinning and other
similar techniques have been widely and successfully applied for
the production of tubular scaffolds.
Rolling
Rolling mechanisms involve the rolling of a flat substrate
into a tube. Rolling is usually accomplished using a mandrel
to manually roll the substrate. However, some studies have
generated tubes with stratified cell layers using a self-assembly
mechanism based on properties of the underlying substrate
(Figure 5). Some of the earlier studies to produce tubular
scaffolds for tissue engineering used rolling methodologies.
Generally, these studies would produce a polymeric sheet and
stitch the sheet into a tube (Niklason and Langer, 1997;
Niklason et al., 1999; Niklason et al., 2001; Gui et al., 2011; 2016).
Other studies developed the use of cell-derived ECM sheets that
were rolled into tubes using a mandrel (L’Heureux et al., 1998,
2006; Pricci et al., 2009; Konig et al., 2009; Gauvin et al., 2010;
Jung et al., 2015). This approach was particularly interesting
in its use of only biological materials. In these studies, ECM-
producing cells were grown to confluence. The resulting ECM
sheet was then detached and rolled into a tube, where further
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FIGURE 5 | Example of rolling process for a vascular tissue engineered tubular construct (Cheng et al., 2017). (A–I) Schematic detailing process for producing
cell-seeded, stress-induced rolling membrane (SIRM). (A–C) Poly(dimethyl siloxane) (PDMS) substrate is coated with poly(DL-lactide-co-glycolide) (PLGA) and
poly(ε-caprolactone) (PCL) through electrospinning (ES) under high voltage (HV). (D–F) Resultant substrate is seeded with endothelial cells (ECs), smooth muscle
cells (SMCs), and fibroblasts. (G–I) Scaffold is released from pre-stressed substrate, causing rolling. (J,K) Resultant stratified cell layers in rolled substrate: ECs are
shown in green, SMCs are shown in blue, and fibroblasts are shown in magenta. Images were reordered from multiple panels, and lettering has been relabeled for
consistency as part of this review article (Cheng et al., 2017).
cells could be seeded. One study used an electrospun scaffold to
assist in rolling a cell sheet into a tubular construct (Rayatpisheh
et al., 2014). Other studies also focused on rolling polymeric
sheets around a mandrel (Shen et al., 2003; Wang et al., 2016b,
2018). More recently, groups have developed self-assembling
tubes. Self-assembly mechanisms or other rolling strategies that
can be performed sterilely have the major benefit of allowing
for cell seeding prior to rolling. Rolling is initiated in these
studies using either mechanically tensioned sheets bound (Cheng
et al., 2017) or shape-memory polymers (Zhao et al., 2018). In
either of these scenarios, cells can be homogeneously seeded
and cultured in 2D and then rolled into a 3D tube (Figure 5).
This strategy allows for the effective production of a confluent
monolayer of epithelial cells on a structure easily compatible with
typical cell culture techniques, while still ultimately producing a
tubular tissue engineered structure. However, once the structure
has been rolled, the sealing of the tube from the free edges of the
rolled substrate needs to be addressed. Many strategies simply use
multi-layered tubes, but this approach can potentially limit media
access to the basal side of the seeded cells. Alternatively, tubes
can be closed with stitching, as described above, or through use
of a sealant to seal the free edges of the tube (Grikscheit et al.,
2002, 2004). Rolling is perhaps the only manufacturing method
that most specifically applies to tubular scaffold production, and,
as such, has had significant impact on this field.
3D Printing
3D printing, also known as additive manufacturing or bioprinting
in some tissue engineering cases, is the process of forming
a 3D structure in a layer-by-layer manner. Printing processes
typically involve extrusion of a material from a nozzle or
photo-crosslinking of an object from a liquid precursor. In
extrusion-based 3D printing, a liquid material, similar to those
used for casting approaches, is extruded from a nozzle onto
a platform. The nozzle follows a fabrication path across the
platform, generating a single layer of the ultimate desired shape.
Once this layer has set, the nozzle ejects a second layer of material
on top of the initial layer, thereby constructing a 3D object (Zhu
et al., 2016). This type of 3D printing is compatible with most
material types, including hydrogels and hydrogels containing live
cellular populations. One study used polymeric scaffolds and
cell-seeded hydrogels to produce layered structures containing
multiple cell populations for construction of a tissue engineered
trachea (Figure 6). For bioprinting applications, cell-seeded
hydrogels or other cell-compatible, printable materials are often
called bioinks. However, specialized printers can be required
depending on the material. Another format of 3D printing
involves the photo-crosslinking of a polymer precursor from a
liquid bath. In these printers, the precursor is cross-linked and
fused to a baseplate, which is moved in 3D as subsequent layers
are crosslinked onto the initial layer, generating 3D structures in
this manner. This type of printing is typically performed using
a photo-initiated cross-linker, meaning that material choices are
limited to those which can be constructed as such. Inkjet printing
is also frequently used in biological applications, but this type of
printing is not typically compatible with the creation of large, 3D
scaffolds like those used for tissue engineering and, as such, will
not be discussed here. Other novel types of printing are also being
developed, which will undoubtably apply to the production of
tubular scaffolds. Various reviews have specifically focused on 3D
printing for tissue engineering and the available methods (Wang
et al., 2015; Zhu et al., 2016; Galliger et al., 2019).
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FIGURE 6 | Example of 3D printing process for construction of tissue engineered trachea (Park et al., 2019). (A) Image showing 3D printing of alginate into a
cell-compatible hydrogel. (B) Image of 3D printed trachea. Scaffold consisted of 5 layers (innermost to outermost): gridded pattern of poly(capralactone), alginate
hydrogel containing primary nasal epithelial cells, cylindrical pattern of poly(capralactone), alginate hydrogel containing primary auricular chondrocytes, gridded
pattern of poly(capralactone). (C) SEM image showing lamellar structure of scaffold. (D–F) Fluorescence microscopy images showing stratified cell layers in scaffold
cross-section. Epithelial cells are shown in green, and chondrocytes are shown in red. Images were reordered from multiple panels, and lettering has been relabeled
for consistency as part of this review article (Park et al., 2019). These images are reprinted under Creative Commons Attribution 4.0 International License, available at
http://creativecommons.org/licenses/by/4.0/.
A major advantage to the 3D printing process is the potential
for easily customizable scaffolds and, when using compatible
printers, the potential print materials containing live cells (Park
et al., 2019; Cui et al., 2019). Unlike casting, this type of
bioprinting is more easily compatible with the generation of
stratified layers of cells. However, the resolution of bioprinters is
often limited due to the viscous properties of biomolecular pre-
gel solutions. Studies have directly examined the optimization
of these properties to enhance bioprinting efforts (Diamantides
et al., 2019). Excluding bioprinting, other 3D printed scaffolds
suffer from the same drawbacks in cell seeding as cast or
electrospun scaffolds but can still produce functional tubular
scaffolds (Melchiorri et al., 2016; Gao et al., 2017; Rabionet
et al., 2018; Hsieh et al., 2018; Park et al., 2018; Xia et al.,
2019). 3D printing methodologies are also compatible with other
techniques discussed in this review. For example, one study
focused on the construction of a 3D printed scaffold, which was
then molded with a cell-laden hydrogel through casting (Gao
et al., 2019). Another study used a combination of 3D printing
and electrospinning techniques (Ahn et al., 2019). Studies are
now increasingly focusing on the use of 3D printing to create
vascular structures (Abaci et al., 2016; Lei et al., 2019), which
could potentially be used to provide nutrients to larger structures,
such as intestinal models. Recently, some studies have printed
a trachea directly using spheroid cell cultures (Taniguchi et al.,
2018; Machino et al., 2019). These studies and others demonstrate
the wide applicability and relevance of 3D printing in various
areas of these fields.
Decellularization
Decellularization involves the production of a scaffold from
native tissue. This field encompasses a wide variety of
applications, from whole organ decellularization (Gilbert et al.,
2006; Crapo et al., 2011) to decellularization of specific tissues
and engineering of these structures for other uses (Lee et al.,
2012; Boys et al., 2019). Generally, decellularization proceeds
through the explanation of a native tissue and then treatment
for the complete removal of cells from the tissue. For cell
removal, the tissue is typically subjected to a series of washes
with enzymes or detergents to lyse and remove the native
population of cells. After removal, the resultant tissues are washed
further or lyophilized to prepare the structure as a scaffold for
tissue engineering (Gilbert et al., 2006). In tissue engineering
applications, decellularized scaffolds may be used for allograft
transplantation or implantation. However, the scaffold must
also be re-seeded with an appropriate cellular population to
recapitulate the desired tissue system in vitro (McFetridge et al.,
2007; Xi-Xun et al., 2008; Yang et al., 2009; Neff et al., 2011;
Zang et al., 2013; Bertanha et al., 2014). Recellularization is
often accomplished through perfusion of the scaffold with a new
cellular population. Decellularization methods are not reserved
exclusively for mammalian tissues. Some studies have shown
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FIGURE 7 | Example of engineered decellularized scaffold for vascular engineering (Quint et al., 2011). Scaffolds were produced by seeding smooth muscle cells
onto a poly(glycolic acid) mesh. The scaffolds were cultured until the cells produced a contiguous ECM throughout the mesh and the mesh was almost entirely
degraded. At this point, the scaffolds were decellularized, resulting in a cell-derived ECM tubular scaffold. Ultimately, scaffolds were re-seeded with endothelial cells
and implanted in a porcine model. (A) Image of decellularized tubular scaffold. (B) Hematoxylin and eosin histological staining of cross-section of scaffold.
Hematoxylin and eosin staining of scaffold microstructure (C) before decellularization and (D) after decellularization. Scale bars are 500 µm. Images were reordered
from multiple panels, and lettering has been relabeled for consistency as part of this review article (Quint et al., 2011).
viable cell attachment and growth on cellulose scaffolds derived
from applies (Modulevsky et al., 2014).
Decellularization has multiple advantages. First, the scaffold
will inherently consist of a highly biocompatible material, which
can assist in tissue production and maturation of the scaffold,
with studies showing that similar cellular populations can be
effectively re-seeded onto decellularized scaffolds. Typically,
these scaffolds are also of sufficient mechanical strength for
the specified application, given their origin. The scaffolds will
also likely contain matrix-bound growth factors and other
biochemical cues that can influence cell behavior upon re-seeding
(Zhou et al., 2020). Some studies have also tissue engineered
cell sheets, decellularized these sheets, and then used them for
re-seeding with a new cellular population (L’Heureux et al.,
1998; Quint et al., 2011). This approach can produce entirely
biologically derived scaffolds (Figure 7), with the particular
advantage of potential usage of only autologous cells and
components. Decellularization has been used jointly with many
other methods for tubular scaffold production. One study
wrapped a cell-seeded, electrospun scaffold around decellularized
aorta fitted with a cast polymeric stent as mechanical support for
tracheal tissue engineering application (Ghorbani et al., 2017).
Decellularized tissue will also usually maintain its native
structure to some extent (Totonelli et al., 2012), which can be
useful. However, the resultant properties of the decellularized
tissue will likely be altered during the decellularization process
(Partington et al., 2013). Decellularized tissues need to undergo
significant characterization to ensure that the resulting scaffold
can still be used in the desired application. Many studies have
utilized decellularized tissues originating in regions differing
from the ultimate region of application, i.e., use of decellularized
amniotic membrane as a vascular scaffold (Lee et al., 2012).
While this strategy may be very effective, the presence of matrix-
bound growth factors that are not associated with the desired
tissue can affect the behavior of the newly seeded cells. A major
disadvantage to the use of decellularized scaffolds is sourcing the
tissue for decellularization. Typically, researchers use xenografts,
which can potentially initiate negative responses depending on
the origin of the scaffold and re-seeded cells. Secondly, the use
of tissue derived from organisms can induce high variability
between scaffolds. However, with proper quality control and
analysis, decellularized scaffolds are a powerful tool in the tissue
engineering of tubular systems.
Other Methods
Various other methods exist for modeling tubular systems.
Most notable among these is the use of microfluidic systems.
Microfluidic systems typically utilize 2D cell culture, which
is compatible with epithelial cultures. As such, various
advancements in our understanding of cellular mechanisms
have been developed through microfluidics. These structures are
generally not tubular or 3D, and we, therefore, have not included
them in our review of available manufacturing mechanisms for
tissue engineered scaffolds. However, microfluidic technologies
for epithelial engineering have been extensively reviewed
elsewhere (Wong et al., 2012; Ahadian et al., 2018).
STATE-OF-THE-ART FOR TUBULAR
TISSUE ENGINEERING
Here, we discuss specific applications for the manufacturing
techniques discussed above. As mentioned in the introduction,
we will focus on tissue engineered vasculature, intestine, and
trachea, particularly considering systems that have applications
in drug testing and discovery.
Vascular Systems
Vasculature is one of the most commonly tissue engineered
structures in the body. Various reviews have been specifically
written about tissue engineering vasculature (Nerem and Seliktar,
2001; Stegemann et al., 2007; Song et al., 2018), with reviews even
written specifically about using electrospinning for vascular tissue
engineering (Rocco et al., 2014). Here, we seek to highlight some
of the innovations in vascular tissue engineering from a tubular
scaffold manufacturing standpoint in addition to discussing
recent approaches.
Many tissue engineered vascular models rely on a population
of smooth muscle cells to produce the relevant ECM on the
scaffold support (Seliktar et al., 2003; McFetridge et al., 2007;
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Lee et al., 2007; Nieponice et al., 2008; Zhang et al., 2013;
Strobel et al., 2018a). However, some systems have also
used fibroblasts, mesenchymal stem cells, or other stem-
like progenitors for this purpose (Shin’oka et al., 2005; Vaz et al.,
2005; Wang et al., 2009; Rayatpisheh et al., 2014; Bertanha et al.,
2014; Jung et al., 2015; Gui et al., 2016; Rabionet et al., 2018;
Strobel et al., 2018b). Much of the literature regarding vascular
design is targeted at the ultimate use of the structure as
an implant or vascular graft. This objective allows for the
endothelialization of the structure in vivo. However, for
benchtop models, endothelial cells must also be included. Some
models have utilized only endothelial cells (Matsuda, 2004;
Lovett et al., 2007; Xi-Xun et al., 2008; Zhang et al., 2013; Wang
et al., 2014; Zhou et al., 2016; Zhao et al., 2018), but many of
the more complex models involve a co-culture of endothelial
cells with an ECM-depositing cell type (Niklason and Langer,
1997; L’Heureux et al., 1998; Niklason et al., 1999; Boland et al.,
2004; Opitz et al., 2004; Swartz et al., 2005; L’Heureux et al., 2006;
Lovett et al., 2008; Yang et al., 2009; Neff et al., 2011; Han et al.,
2011; Cheng et al., 2017; Ju et al., 2017; Atchison et al., 2017; Cui
et al., 2019; Atchison et al., 2020).
Given the layered structure of native blood vessels
(Figure 1A), many models utilize an approach where the
ECM-forming cell type is first seeded, followed by a secondary
seeding step of endothelial cells. This seeding method is
compatible with virtually any tubular scaffold construction. An
earlier model for tissue engineered vasculature used a series
of three layers to mimic native vascular structure. The basis
for the scaffold was formed through a fibroblast-derived cell
sheet that was rolled into a multi-layered tube. The layers fused
together in culture before subsequent dehydration, resulting in
decellularization, for further seeding. This support tubing was
wrapped with a second, living sheet of fibroblasts followed by
injection of endothelial cells into the lumen, at which point the
vessel was subjected to fluid shear (L’Heureux et al., 2006). This
model was not used as a benchtop system but was ultimately
implanted into humans (L’Heureux et al., 2007), significantly
driving the field of vascular tissue engineering forward. However,
this technique, while generally successful, took an extended
period of culture (∼28 weeks) to produce the finalized vessel.
Various early studies solidified the usage of stratified cell
layers in vascular tissue engineering, particularly with regard
to different tubular scaffold construction methodologies. Some
studies focused on the initial seeding of the scaffold with smooth
muscle cells or fibroblasts (Boland et al., 2004; Yang et al.,
2009; Neff et al., 2011). Other studies used cell-compatible
injection molding techniques to create a tissue-like structure
as the scaffold (Swartz et al., 2005; Liu et al., 2007). Some
of these studies were able to demonstrate response of smooth
muscle cells to vasoactive reagents, indicating the potential of
these constructs for drug testing (Swartz et al., 2005; Liu et al.,
2007). However, these particular studies produced structures that
lacked an endothelium for these tests (Swartz et al., 2005; Liu
et al., 2007), limiting similarity to native tissue. A more recent
study used a rolling technique to produce the medial/adventitial
regions of the blood vessel (Jung et al., 2015). Mesenchymal
stem cells were used to produce cell sheets, which were rolled
into a tube with four concentric layers. These sheets fused
together during culture in a bioreactor. The lumen was then
seeded with a population of endothelial progenitor cells and
cultured under flow conditions. Exposure of the vessels to a
vasoconstrictor, phenylephrine, elicited a constrictive response
by the cells. The vessels also dilated under increased flow. The
study also examined the adhesion of monocyte-like cells under
exposure of the vessel to TNF-α, an inflammatory cytokine. TNF-
α can upregulate production of adhesion molecules on vascular
walls to aid in leukocyte binding. Increased binding was observed
for this system with exposure to TNF-α. However, the researchers
did not analyze their structures for the formation of endothelial
junctions (Jung et al., 2015).
Another study focused on the development of a bioink and
a co-axial extrusion printer system to enable the direct printing
of tubular structures containing cells (Cui et al., 2019). In this
setup, the walls of the resultant vessel were constructed of
crosslinked gelatin methacrylate, containing smooth muscle cells.
The lumen was formed by extruding Pluronic F127, a bioinert
polymer surfactant hydrogel which can be dissolved under
certain conditions, containing endothelial cells. The structure was
allowed to set before the Pluronic F127 layer was removed from
the lumen. During the removal process, some of the endothelial
cells adhered to the interior walls of the lumen, resulting in
a gelatin methacrylate layer containing smooth muscle cells
with an interior lining of endothelial cells, remnant after the
lumen clearance. Vascular permeability was assessed on similar
structures possessing a non-tubular geometry, finding that the
endothelial layer showed decreased permeability. The structures
were also subjected to a vasodilator, acetylcholine, and showed
dilation upon exposure (Cui et al., 2019). A major benefit to
structures produced in this manner, or similar manners, is the
vast array of feasible shapes and channels that can be produced
through 3D printing. Studies are increasingly focusing on the
development of microvasculature (Wang et al., 2014; Abaci
et al., 2016; Lei et al., 2019), which can provide more realistic
environments in other models, such as the intestine.
Various models have also been produced to mimic and
study specific disease states. Tissue engineered vasculature
was developed to model Hutchison-Gilford Progeria Syndrome
(HGPS), which is associated with increased prevalence of
cardiovascular disease and is associated with dysfunctional
smooth muscle cells in vasculature (Atchison et al., 2017,
2020). This model was developed using induced pluripotent
stem cells (iPSCs) and endothelial progenitor cells. The iPSCs
were derived from healthy fibroblasts or fibroblasts an HGPS
mutation, then differentiated toward smooth muscle cells. Tissue
engineered vasculature was constructed by injecting collagen,
containing smooth muscle cells, into a mold, following by
gelation of the cell-seeded collagen. Endothelial progenitors were
then perfused into the lumen for seeding (Atchison et al.,
2017, 2020). The authors were able to observe differences in
vasoactivity between healthy and diseased cells, as monitored by
examining vasodilation and vasoconstriction using acetylcholine
and phenylephrine, respectively (Atchison et al., 2020). This
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study and others highlight the major potential for use of tissue
engineered vasculature as a model for drug testing/discovery.
Intestinal Systems
Intestinal tissue engineering represents a particularly challenging
field in the difficulty of producing a functional intestinal
epithelium, given the numerous types of epithelial cells present
in the native intestine. Further, the intestine has a complex 3D
cross-section of villi and crypts, which also relates to the cellular
distribution in the intestine (Santos et al., 2018). To reconstitute
these structures, numerous studies have developed intestinal
models using microfluidics or 2D cell culture substrates.
However, these models do not fully mimic the complex native
environment of the intestine (Bein et al., 2018). As such, 3D tissue
engineered models have also been developed, which allow for the
recapitulation of some of the aspects of the native intestine.
Some of the earlier tissue engineered models of the
intestine were developed by rolling polymeric tubes and seeding
these scaffolds with organoids derived from native murine
colons. These structures were successfully transplanted into rats
(Grikscheit et al., 2002). These structures were also used to treat
induced short bowel syndrome in rats. The tissue engineered
structures were beneficial for survival and gut function versus
sham controls (Grikscheit et al., 2004). These studies indicated
the possibility for the development of further tissue engineered
benchtop models.
One model developed non-tubular 3D villus and crypt
geometries using casting techniques (Yu et al., 2012). Scaffold
construction was performed by casting collagen onto a negative
of the villus-crypt structure. These structures were seeded with
an enterocyte-like cell line (Caco-2 cells) and analyzed versus a
flat system, i.e., without villi. The permeability of the cellularized
structures was gauged using electrical measurements I and
permeation by two drugs, finding higher permeability coefficients
in the 3D structures (Yu et al., 2012). This experimental design
has since been used with various other materials, mainly porous
polymeric structures, to monitor the effects of bacterial culture
with enterocytes (Costello et al., 2014; Ladd et al., 2019) and has
recently been formed into tubular structures for implantation
(Ladd et al., 2018).
Perhaps one of the most complete tissue engineered tubular
models was developed for the intestine, using a cellularized,
stratified silk scaffold (Chen et al., 2015) with a bioreactor,
designed to simulate gut motility (Zhou et al., 2018). A casting
approach was used to generate tubular silk scaffolds (Figure 3).
Primary intestinal myofibroblasts were seeded within collagen
into the silk scaffold and the interior lumen was subsequently
lined with a co-culture of an enterocyte-like cell line (Caco-
2) and goblet-like cell line (HT29-MTX) by luminal injection.
The resultant cultures showed mucus production and tight
junctional formation throughout the epithelial cell layer. Further,
an intraluminal oxygen gradient was detected (Chen et al., 2015).
Iterations on this model have also included colonoid-derived
epithelium (Chen et al., 2017) with monocyte cultures and
examination for macrophage infiltration through the epithelium
(Roh et al., 2019). A bioreactor was also developed and applied
to this system to provide pulsatile, peristaltic-like stimulation to
these constructs (Zhou et al., 2018).
Many other non-tubular systems have also successfully
modeled various aspects of the gastrointestinal tract. For
example, an extensive bioreactor system was developed to
simulate the microbial populations of the intestine (Van den
Abbeele et al., 2012). A recently developed microfluidic model
was also able to recapitulate the intestinal epithelium and
associated microbial population with an adjacent vascular
structure (Jalili-Firoozinezhad et al., 2019). This design
resulted in the formation of a villus-crypt structure with
polarized epithelial cells. This device also included sensors
for monitoring oxygen content non-invasively, allowing for
monitoring of oxygen gradients between the intestinal lumen
and adjacent vascular lumen chambers (Jalili-Firoozinezhad
et al., 2019). These types of devices are particularly useful
as basic science platforms and can help inform the design
of larger tubular systems. Currently, many of the tissue
engineered intestinal models are focusing on the examination
of the gut microbiome or immune components. As these
models are developed further and our understanding
of some of these aspects of intestinal biology improves,
focus will likely shift to the testing of drugs in these tissue
engineered systems.
Tracheal Systems
Unlike the in vitro models discussed for vasculature and
the intestine, the outlook for tracheal tissue engineering
to date largely concerns implantable scaffolds for tracheal
replacement. In recent years, research has been targeted toward
improving in vitro preparation methods such as optimizing
decellularization through enzymatic, detergent (Zhong et al.,
2019), vacuum-assisted (Butler et al., 2017), and chemical-
based techniques (Batioglu-Karaaltin et al., 2019). For example,
enhanced enzymatic approaches have drastically reduced tracheal
decellularization time (Giraldo-Gomez et al., 2019; Wang et al.,
2020). Importantly, the reduced preparation time had no adverse
effects on tracheal ECM structure or biomechanical properties
and evaded immunogenic or inflammatory responses when
implanted in vivo. This result highlights the promise of advanced
decellularization methods for production of tracheal implants.
Despite success in these areas, decellularization methods require
availability of human tracheal donors, and decellularized scaffolds
can possess altered mechanical properties compared to native
(Partington et al., 2013).
A major requirement for tracheal tissue engineering is
sufficient mechanical support to resist pressurization. As such,
many tissue engineered tracheal models have been created
through combination of different manufacturing methods,
incorporating a mechanical support structure with a cell-
seedable scaffold. Tissue engineered trachea have been produced
using a combination of 3D printing and decellularization
methodologies (Johnson et al., 2016). This approach offers
many advantages, including improved structural and mechanical
support versus decellularized tissue alone, while maintaining
biocompatibility and a native-like ECM. These hybrid 3D
printed-decellularized scaffolds showed comparable resistance
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to compression versus native tissue and higher resistance to
compression versus a decellularized scaffold alone (Johnson et al.,
2016). Scaffolds produced through combination of 3D printing
and electrospinning also possessed sufficient mechanics (rotation
angle, elastic modulus, elongation ratio, and tensile strength)
for recapitulation of the trachea, while still demonstrating
a high degree of cellular attachment (Ahn et al., 2019).
Other studies have mimicked native tracheal structure by
incorporating C-shaped rings onto 3D printed tubular designs,
thusly producing similar mechanical profiles to in vivo (Ott et al.,
2016; Best et al., 2018).
Other studies have looked to characterize biocompatibility
and regenerative capabilities of tracheal grafts via transplantation
into rabbit models. For example, 3D solvent-based casting
techniques have been utilized to fabricate tubular scaffolds,
which demonstrate vascularization and differentiation of ciliated,
mucus producing tracheal epithelium 4 weeks post-implantation
(Park et al., 2015). Similarly, 3D bioprinting of a tubular
tracheal tissue, containing layers of PCL and autologous epithelial
cells and chondrocytes (Figure 6), demonstrated complete
regeneration of respiratory epithelium and long-term stability of
tracheal function (Park et al., 2019). However, further studies are
needed to assess possibility of adverse immune or inflammatory
processes and to promote chondrocyte regeneration of cartilage
for mechanical support. Additionally, sufficient luminal airflow
and gas tightness is necessary (Hsieh et al., 2018) and
fundamental to the success of tracheal implants when positioned
at the native air-liquid interface.
In summary, many studies have shown the successful
fabrication of layered, flexible and structurally supportive tubular
tracheal models, with characterization and comparisons made
in vitro using techniques such as high-resolution microscopy,
immunofluorescence, histological staining, and mechanical
testing. Although some studies have looked to address microbial
properties and response to pathogen invasion (Kang et al., 2019),
to date, most tissue engineered tracheal model systems focus on
developing implantable scaffolds. The limited examples of models
which address toxicology or drug testing may be associated with
the difficulty of established a 3D air-liquid interface in vitro.
Further, the use of high throughput microfluidic and 2D systems
for drug stimulation and discovery is well-established in this field
(Ahadian et al., 2018).
FUTURE PERSPECTIVES
The field of tissue engineering for tubular systems has undergone
various innovative steps over the course of its history. However,
tissue engineered models still do not fully resemble native
tissue. This lack of resemblance is partially due to the
numerous cell types that require representation. For example,
few systems include neural and immune components, which
are increasingly connected to tissue function and homeostasis
(Veiga-Fernandes and Artis, 2018). Further, in intestinal tissue
engineering, numerous cell types are necessary for making only
the epithelium, which can drastically complicate culture setup.
Further innovations in scaffold manufacturing have the potential
to solve these issues. Bioprinting can potentially place various
cell types in a stratified manner, increasing the feasibility of
producing cellularly complex systems. However, the cost of
producing or purchasing a bioprinter capable of constructing
such stratified structures is currently too high to be widely
available. As such, innovations in the surrounding technologies,
i.e., multi-nozzle systems, integrated culture capabilities, etc.,
can significantly increase feasibility. Other techniques involving
tubular self-assembly can accomplish some of these tasks at lower
cost. Researchers should also consider the production of modular
systems for improving model complexity. Designing scaffolds
that can be placed into a co-culture upon reaching maturity
allows for a wider range of culture conditions and experiments
without necessarily requiring expensive fabrication equipment.
Other factors complicating current efforts in tubular tissue
engineering involve the application of native-like conditions
to the resultant scaffolds. For example, while some studies
have developed native-like culture conditions using bioreactors
(Zhou et al., 2018), most studies rely on media conditions
to produce tissue models. Many of the cells present in these
systems are mechanoresponsive, as evidenced by the dynamic
physiological conditions in vivo, indicating that further stimuli
must be applied to reach native-like conditions in vitro.
For this particular limitation, study designs must consider
compatibility of the scaffold with a subsequent bioreactor system.
Scaffolds can potentially be fabricated inside a bioreactor using
many of the techniques above, such casting and printing.
Alternatively scaffolds can be produced with dynamic material
components, like piezoelectric materials, that can potentially
provide mechanical stimuli to a scaffold using an inherent
material property.
A final piece to consider for improving tubular scaffold
efficacy is engineering of scaffold walls to generate multiple
cellular microenvironments within a singular scaffold. For
example, scaffolds can be produced to support formation of
microvasculature (Chang and Niklason, 2017). Use of such
a scaffold in an intestinal tissue engineering application can
provide cells with nutrients through microvasculature channels,
which can theoretically simplify bulk fluidic bioreactor designs.
Similar concepts can be applied to tracheal tissue engineering,
in designing scaffolds that can support cartilage formation, while
simultaneously providing a face for epithelial formation. Many of
the scaffold manufacturing techniques presented in this review
have the potential for microstructural engineering within the
scaffold bulk, and consideration of desired microenvironments
when designing a fabrication process can have considerable
benefits in the final results.
As tissue engineered tubular systems progress toward
functional tissues, these systems can be used for drug testing
and discovery. Many systems have already begun to show
active responses to different drugs (Jung et al., 2015; Atchison
et al., 2017, 2020). However, a major factor that is still lacking
is the ability to monitor these systems in real-time. Most
tissue engineered systems, particularly those with 3D structural
features, require endpoint analysis. Studies typically use analytical
techniques like immunostaining or blotting to determine the
cellular response and activity in the tissue engineered system.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 14 December 2020 | Volume 8 | Article 589960
fbioe-08-589960 December 6, 2020 Time: 13:42 # 15
Boys et al. Tissue Engineering Tubular Scaffolds
While these techniques are very useful and informative, they can
also result in a lengthened study period, in that they will often
require titration or larger sample numbers to reach sufficient
statistical power for analysis.
Some studies have begun to integrate non-invasive techniques,
like electrical measurements, that can be performed during
culture. These techniques provide real-time data on the tissue
engineered system that can be compared to typical endpoint
analyses. For example, a common method for assessing epithelial
barrier formation, with reference to drug or toxicology studies,
is transepithelial electrical resistance (TEER) (Benson et al.,
2013; Srinivasan et al., 2015). However, TEER apparatus are
somewhat limited due to the rigid structure of electrode
probes, which fails to conform to the complex architecture of
advanced tissue engineered models. Other common means for
monitoring tissue engineered tubular models include various
material analyses, such as mechanical analysis, or biological
analytical methods, such as histology and immunostaining.
However, these methods are also more difficult to apply in
tubular scaffolds due to their geometry, further complicating
assessment in these tissue engineered systems. In answer to these
limitations, some innovative solutions have been demonstrated
including the use of an electroactive polymer scaffold, which
can monitor real-time cell adhesion, growth, and migration
during culture (Pitsalidis et al., 2018), with potential for a
tubular setup for tissue engineering. Additionally, electrodes have
been fabricated in organ-on-chip devices (Henry et al., 2017),
microfluidics (Curto et al., 2017), and flexible polymer substrates
(Ferro et al., 2019; Kalmykov et al., 2019) to monitor barrier
integrity in complex cell cultures. These examples highlight the
potential of flexible and microelectronic fabrication methods
in monitoring complete barrier formation in future 3D tissue-
engineered models. However, while measurements like TEER, are
very common in 2D systems, these measurements have not yet
been widely adapted to larger-scale 3D systems.
Overall, we have discussed the various mechanisms by which
tubular scaffolds can be constructed for tissue engineering.
We divided the available manufacturing methodologies into
five major categories: casting, electrospinning, rolling, 3D
printing, and decellularization. Innovations for every one of
these methodologies are still being generated today, with
continuous new advancements in fabrication of scaffolds and
tissue engineered systems. Methods like 3D printing and self-
assembled rolling scaffolds allow for simultaneous advancements
in ease of manufacturing and system complexity, driving toward
tissue engineered systems that truly mimic native tissues. As these
systems are developed, we will soon see their viable use in testing
drug safety and efficacy in future biomedical studies.
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